Burn Care Market Size, Share, Growth & Industry Analysis, By Cause (Thermal Burns, Electrical Burns, Radiation Burns, Chemical Burns, Friction Burns), By Product (Advanced Burn Care Products, Biologics, Traditional Burn Care Products, Others), By End-User, By Burn Depth, and Regional Analysis, 2024-2031

Market Definition

The burn care market involves the development and distribution of products and treatments aimed at addressing burn injuries. It includes wound care products, medical devices, and pharmaceutical solutions designed to promote healing, prevent infection, reduce pain, and minimize scarring.

This market focuses on both acute and chronic burn management, offering advanced therapies and technologies to support recovery and improve patient outcomes.

Burn Care Market Overview

The global burn care market size was valued at USD 2,580.0 million in 2023 and is projected to grow from USD 2,742.7 million in 2024 to USD 4,476.7 million by 2031, exhibiting a CAGR of 7.25% during the forecast period.

The expansion of healthcare infrastructure, including the establishment of more hospitals, clinics, and specialized burn units, improves accessibility to burn care products. This growth enables timely treatment and better management of burn injuries, contributing to the overall demand for burn care solutions.

Major companies operating in the global burn care industry are 3M, Hollister Incorporated, Cardinal Health, Coloplast Group, DeRoyal Industries, Inc., Smith+Nephew, Convatec Inc., Mölnlycke Health Care AB, Medtronic, Anika Therapeutics, Inc., B. Braun SE, Medline Industries, LP, PAUL HARTMANN AG, Essity Aktiebolag, and MIMEDX Group, Inc..

The burn care market is focused on delivering advanced solutions for the treatment and management of burn injuries. It encompasses a range of products and therapies aimed at alleviating pain, promoting healing, and minimizing complications. The market is characterized by continuous innovation and evolving treatment options to improve patient care.

As medical technologies advance, the market is becoming more specialized, offering tailored solutions to address varying degrees of burn injuries. The emphasis remains on enhancing recovery, minimizing scarring, and improving overall patient quality of life.

• In June 2024, Penn State's research into 3D bioprinting of living tissues, including skin and organs, made significant strides. The development of bioengineered skin layers, including hair follicles, aims to improve reconstructive surgery outcomes and burn care solutions.

Key Highlights:

1. The global burn care market size was recorded at USD 2,580.0 million in 2023.
2. The market is projected to grow at a CAGR of 7.25% from 2024 to 2031.
3. North America held a market share of 36.61% in 2023, with a valuation of USD 944.5 million.
4. The thermal burns segment garnered USD 957.7 million in revenue in 2023.
5. The advanced burn care products segment is expected to reach USD 1,845.6 million by 2031.
6. The hospitals segment held a market share of 37.14% in 2023.
7. The partial-thickness burns segment is expected to grow at a CAGR of 8.07% during the forecast period.
8. The market in Asia Pacific is anticipated to grow at a CAGR of 7.97% during the forecast period.

Market Driver

"Impact of Rising Burn Injuries on Market Growth"

The rising incidence of burn injuries is driving the burn care market. Accidents, industrial exposure, and household incidents contribute to an increase in burn cases, which, in turn, elevates the demand for effective burn care products.

• According to the World Health Organization (WHO), burns represent a significant global public health issue, with an estimated 180,000 fatalities occurring each year. A large proportion of these deaths occur in low- and middle-income countries. Non-fatal burns also contribute substantially to morbidity, often leading to extended hospital stays, disfigurement, disability, and, in many cases, social stigma, and rejection.

The increasing number of burn injuries is boosting the need for advanced treatments, wound management solutions, and rehabilitation therapies, prompting the market to innovate and expand to meet these growing healthcare needs.

• In March 2023, Convatec received FDA clearance for its InnovaBurn placental extracellular matrix device, designed for managing complex surgical wounds and burns, including partial-thickness second-degree burns. The device, part of the InnovaMatrix platform, offers innovative technology for wound healing, with ease of use and affordability for larger burn wounds.

Market Challenge

"Addressing Limited Awareness and Enhancing Burn Care Through Skin Donation Programs"

Limited public awareness about burn prevention, early treatment, and advanced burn care products remains a significant challenge in the burn care market. Many individuals are unaware of effective prevention measures or the importance of seeking timely medical attention. Hence, increasing awareness on burn care and promoting the benefits of skin donations can be crucial.

Skin donation programs can provide life-saving grafts for burn victims, enhancing recovery outcomes. Collaboration between healthcare organizations, governments, and communities can play a vital role in raising awareness and improving access to burn care.

• In June 2023, marked the launch of North Kerala’s first Skin Bank, a collaborative effort between the Rotary Club and Aster MIMS, Calicut. This initiative aims to provide skin grafts to burn patients, addressing the critical need for recovery and transforming burn care in the region.

Market Trend

"Focus on Scar Management and Esthetic Results"

The burn care market is increasingly prioritizing scar management and esthetic outcomes. As patients and healthcare providers recognize the importance of minimizing scarring, innovations are emerging to improve cosmetic results after burn injuries.

Advanced dressings, and surgical techniques are being developed to promote better healing, reduce the appearance of scars, and enhance the overall quality of life for burn survivors, ensuring both functional recovery and improved aesthetics.

• In July 2024, VCU Health’s Evans-Haynes Burn Center adopted RECELL GO technology, utilizing patients' own skin for faster healing, reducing infection risk, and minimizing scarring, offering a more efficient and customized approach to wound care and recovery.

Burn Care Market Report Snapshot

Market Segmentation:

• By Cause (Thermal Burns, Electrical Burns, Radiation Burns, Chemical Burns, and Friction Burns): The thermal burns segment earned USD 957.7 million in 2023, due to the increasing incidence of burn injuries, coupled with advancements in burn care treatments and therapies.
• By Product (Advanced Burn Care Products, Biologics, Traditional Burn Care Products, and Others): The advanced burn care products segment held 41.44% of the burn care industry in 2023, due to the rising demand for innovative solutions that enhance healing, reduce scarring, and improve recovery times.
• By End-User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics, and Research Institutes): The hospitals segment is projected to reach USD 1,740.0 million by 2031, owing to the increasing number of burn cases requiring specialized care, advanced treatments, and longer hospitalization for severe burn injuries.
• By Burn Depth (Superficial Burns, Partial-Thickness Burns, and Full-Thickness Burns): The partial-thickness burns segment is expected to register a CAGR of 8.07% during the forecast period, due to the rising incidence of moderate burn injuries that require advanced treatment solutions and enhanced recovery options.

Burn Care Market Regional Analysis

North America accounted for a market share of 36.61% in 2023 with a valuation of USD 944.5 million. North America leads the burn care market, due to advanced healthcare infrastructure, high healthcare expenditure, and extensive research and development (R&D) activities. The region boasts state-of-the-art burn centers and hospitals equipped with cutting-edge technologies for burn treatment.

Additionally, a high prevalence of burn injuries and a growing elderly population drive the market. These factors collectively position North America as the foremost region for innovations and investments in burn care solutions.

• In January 2025, as wildfires ravage California, the American Burn Association (ABA) supports burn centers and healthcare providers through various resources. They coordinate disaster preparedness, ensuring rapid, effective responses to wildfire-related burn injuries while providing critical training and support to healthcare systems and responders.

The burn care market in Asia Pacific is poised for significant growth over the forecast period at a CAGR of 7.97%. This is attributed to increasing burn injuries, rising healthcare awareness, and improving medical infrastructure.

Emerging economies are witnessing advancements in burn treatment technologies, alongside growing investment in healthcare services. A rising population, coupled with increased urbanization and industrialization, contributes to more burn incidents, driving he demand for advanced burn care solutions.

Additionally, governments and international organizations are focused on enhancing healthcare access in this region, further accelerating market growth and innovation.

Region’s Regulatory Framework Also Plays a Significant Role in Shaping the Market

• The U.S. follows FDA guidelines for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
• The European Medicines Agency (EMA) protects and promotes human and animal health by evaluating and monitoring medicines within the European Union (EU) and the European Economic Area (EEA).
• In APAC, PMDA (Pharmaceuticals and Medical Devices Agency) is Japanese regulatory agency, working together with Ministry of Health, Labour and Welfare. The agency protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.
• In India, the Central Drugs Standard Control Organisation (CDSCO) is constantly thriving upon to bring out transparency, accountability and uniformity in order to ensure safety, efficacy and quality of the medical product manufactured, imported and distributed in the country.

Competitive Landscape:

The global burn care market is characterized by a large number of participants, including established corporations and rising organizations. Key market participants include 3M, Hollister Incorporated, Cardinal Health, Coloplast Group, DeRoyal Industries, Inc., Smith+Nephew, Convatec Inc., Mölnlycke Health Care AB, Medtronic, Anika Therapeutics, Inc., B. Braun SE, Medline Industries, LP, PAUL HARTMANN AG, Essity Aktiebolag, and MIMEDX Group, Inc., among others.

The market is expanding globally, driven by increasing demand across and thereby, offering greater market potential. Additionally, burn care solutions are increasingly integrated into pediatric care, addressing the unique needs of children and enhancing treatment options for younger patients.

• In August 2024, MediWound Ltd. announced FDA approval for a pediatric indication of NexoBrid (anacaulase-bcdb) for eschar removal in pediatric patients aged upto 18 years with deep partial- or full-thickness burns. This approval expands NexoBrid's use in the U.S., aligning with its EU and Japan approvals.

 List of Key Companies in Burn Care Market:

• 3M
• Hollister Incorporated
• Cardinal Health
• Coloplast Group
• DeRoyal Industries, Inc.
• Smith+Nephew
• Convatec Inc.
• Mölnlycke Health Care AB
• Medtronic
• Anika Therapeutics, Inc.
• Braun SE
• Medline Industries, LP
• PAUL HARTMANN AG
• Essity Aktiebolag
• MIMEDX Group, Inc., and
• Others

Recent Developments

• In November 2024, researchers at The Alfred and Monash University achieved a breakthrough in burn treatment by successfully repairing extensive full-thickness burns with bioengineered skin grown from the patient’s own cells. This innovation reduces the need for grafting and infection risks, improving long-term recovery outcomes.
• In July 2024, Spectral AI expanded its 2024 Burn Pivotal Study with three new U.S. clinical trial sites, bringing the total to 16. The study aims to validate the DeepView System, an AI-driven tool for burn assessment, with plans for FDA approval in 2025 to improve burn care outcomes.
• In February 2024, Spectral AI announced that its DeepView AI-Burn software obtained UKCA authorization for burn wound diagnosis. This milestone allowed the company to sell its DeepView System in the UK, with six devices set for customer evaluation, contributing to revenue growth in 2024 and enabling potential regional expansions.
• In August 2023, FAMU-FSU College of Engineering initiated a five-year, USD 1.3 million research agreement with the U.S. Army to use ultrasound and AI for burn wound analysis. The project aims to improve diagnosis, healing predictions, and treatment decisions, benefiting both medics and patients.
• In January 2023, Convatec launched ConvaFoam, an advanced family of foam dressings designed to simplify wound care for healthcare providers and patients. Addressing hard-to-heal wounds, ConvaFoam offers enhanced adhesion, absorbency, and a seven-day wear time. It also provides educational support through QR codes, promoting better patient compliance and outcomes.